Ken Glasscock

Ken Glasscock is an experienced professional in the field of scientific communications and medical affairs, currently serving as the Executive Director at Adverum Biotechnologies since April 2025. Previously, Glasscock held the position of Senior Director of Scientific Communications at 4D Molecular Therapeutics from March 2022 to June 2025 and was the President at KFG Scientific Communications from July 2015 to March 2021, where expertise included strategic publication planning and impactful scientific messaging. Glasscock has extensive experience in medical affairs, having worked as Vice President and Senior Director at InterMune from June 2000 to June 2015, and held various roles at GlaxoSmithKline from 1992 to 2000. Glasscock's educational background includes studies at Georgetown University (1993-1996) and the University of South Carolina (1984-1988).